FEBNM
Certificate of Fellowship of the European Board of Nuclear Medicine
Neuroendocrine Tumour TheranosticsEnglish
Exam overviewPractice session
A patient with metastatic well-differentiated ileal neuroendocrine tumour is considered for peptide receptor radionuclide therapy. Which imaging pattern most strongly supports suitability for lutetium-177 DOTATATE therapy?
Loading your practice session…